Patient‐Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer

BACKGROUND. This study explores the incidence of patient‐reported major toxicity—symptoms rated “moderate,” “severe,” or “very severe”—for chemotherapy regimens commonly used in early breast cancer. PATIENTS AND METHODS. Female patients aged 21 years or older completed a validated Patient‐Reported S...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Nyrop, Kirsten A., Deal, Allison M., Shachar, Shlomit S., Basch, Ethan, Reeve, Bryce B., Choi, Seul Ki, Lee, Jordan T., Wood, William A., Anders, Carey K., Carey, Lisa A., Dees, Elizabeth C., Jolly, Trevor A., Reeder‐Hayes, Katherine E., Kimmick, Gretchen G., Karuturi, Meghan S., Reinbolt, Raquel E., Speca, JoEllen C., Muss, Hyman B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2018
Konular:
Breast Cancer
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656489/
https://ncbi.nlm.nih.gov/pubmed/30552158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0590
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller